Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 5 , Pages 882-887 , May 2008

Effect of Estrogen on the Expression of Cytokines of the Temporomandibular Joint Cartilage Cells of the Mouse

  • Kyoung-In Yun, DDS, MS, PhD

      Affiliations

    • Assistant Professor, Department of Oral and Maxillofacial Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
  • ,
  • Chang-Hoon Chae, BS, MS, PhD

      Affiliations

    • Adjunct Professor, Department of Dentistry, College of Medicine, Hallym University, Kangwon-do, Korea.
  • ,
  • Cheol-Won Lee, DDS, MSD, PhD

      Affiliations

    • Professor, Department of Dentistry, College of Medicine, Catholic University of Korea, Seoul, Korea.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Lee: Department of Dentistry, St Mary's Hospital, Yoido-dong, Seoul, Republic of Korea

References 

  1. Dworkin SF, Huggins KH, LeResche L, et al. Epidemiology of signs and symptoms in temporomandibular disorders: Clinical signs and cases and controls. J Am Dent Assoc. 1990;120:273
  2. Kapila S, Xie Y. Targeted induction of collagenase and stromelysin by relaxin in unprimed and β-estradiol-primed diarthrodial joint fibrocartilaginous cells but not in synoviocytes. Lab Invest. 1998;78:925
  3. LeResche L, Saunders K, Korff MR, et al. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain. 1997;69:153
  4. Aufdemorte TB, Van Sickels JE, Dolwick MF, et al. Estrogen receptors in the temporomandibular joint of the baboon (Papio cynocephalus: an autoradiographic study). Oral Surg Oral Med Oral Pathol. 1986;61:307
  5. Abubaker AO, Raslan WR, Sortereanos GC. Estrogen and progesterone receptors in temporomandibular joint discs of symptomatic and asymptomatic persons: A preliminary study. J Oral Maxillofac Surg. 1993;51:1096
  6. Abubaker AO, Hebda PC, Gunsolley JN. Effects of sex hormones on protein and collagen content of the temporomandibular joint disc of the rat. J Oral Maxillofac Surg. 1996;54:721
  7. Corvol M, Blanchard O, Tsagris L. Bone and cartilage responsiveness to sex steroid hormones. J Steroid Biochem Mol Biol. 1992;43:415
  8. De Bont LGM, Boering G, Liem RSB, et al. Osteoarthritis and internal derangement of the temporomandibular joint: A light microscopic and scanning electron microscope study. J Oral Maxillofac Surg. 1986;44:634
  9. Yokoo T, Kitamura M. Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am J Physiol. 1996;270:F123
  10. Puzas JE, Landeau JM, Tallents R, et al. Degenerative pathways in tissues of the temporomandibular joint (Use of in vitro and in vivo models to characterize MMP and cytokine activity). Cells Tissues Organs. 2001;169:248
  11. Hussain S, Assender JW, Bond M, et al. Activation of protein kinase Czeta is essential for cytokine-induced metalloproteinase 1-3 and -9 secretion from rabbit smooth muscle cells and inhibits proliferation. J Biol Chem. 2002;277:27345
  12. Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002;39:237
  13. Kubota E, Imamura H, Kubota T, et al. Interleukin-1β and stromelysin (MMP-3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg. 1997;55:20
  14. Kubota E, Kubota T, Katsumoto J, et al. Synovial fluid cytokines and proteinase as markers of temporomandibular joint disease. J Oral Maxillofac Surg. 1998;56:192
  15. Takahashi T, Kondoh T, Fukuda M, et al. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:135
  16. Sandler NA, Buckely MJ, Cillo JE, et al. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements. J Oral Maxillofac Surg. 1998;56:534
  17. Shafer DM, Assael L, White LB, et al. Tumor necrosis factor-α as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg. 1994;52:786
  18. Fu K, Ma X, Zhang Z, et al. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg. 1995;53:424
  19. Habu M, Tomlnaga K, Sukedal M, et al. Immunohistochemical study of interleukin-1β and interleukin-1 receptor antagonist in an antigen-induced arthritis of the rabbit temporomandibular joint. J Oral Pathol Med. 2002;31:45
  20. Rugh JD, Solberg WK. Oral health status in the United States (Temporomandibular disorders). J Dent Edu. 1985;49:398
  21. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cell Tissues Organs. 2001;169:187
  22. Rosner IA, Goldberg VM, Getzy L, et al. Effect of estrogen on cartilage and experimentally-induced osteoarthritis. Arthritis Reheum. 1979;22:52
  23. Rosner IA, Malemud CJ, Goldberg VM, et al. Pathologic and metabolic responses of experimental osteoarthritis to estradiol and an estradiol antagonist. Clin Orthop. 1982;171:280
  24. Rosner IA, Goldberg VM, Moskowitz RW. Estrogens and osteoarthritis. Clin Orthop. 1986;213:77
  25. Yasuoka T, Nakashima M, Okuda T, et al. Effect of estrogen replacement on temporomandibular joint remodeling in ovariectomised rats. J Oral Maxillofac Surg. 2000;58:189
  26. Lanti N, Lombardi I, Manfredini D, et al. Sexual hormone serum levels and temporomandibular disorders (A preliminary report). Gynecol Endocrinol. 2005;20:99
  27. Westling L. Temporomandibular joint dysfunction and systemic joint laxity. Swed Dent J. 1992;81(Suppl):1
  28. Haskin CL, Milam SB, Cameron IL. Pathogenesis of degenerative joint disease in the human temporomandibular joint. Crit Rev Oral Biol Med. 1995;6:248
  29. Alstegren P, Emberg M, Kvamstrom M, et al. Interleukin-1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility and anterior open bite. J Oral Maxillofac Surg. 1998;56:1059
  30. Kacena MA, Merrel GA, Konda SR, et al. Inflammation and bony changes at the temporomandibular joint. Cell Tissues Organs. 2001;169:257
  31. Kapila S. Discussion (Determination of interleukin-1 receptor antagonist, interleukin-10 and transforming growth factor-β1 in synovial fluid aspirates of patients with temporomandibular disorders). J Oral Maxillofac Surg. 1999;57:928
  32. Matrisian LM. Metalloproteinase and their inhibitors in matrix remodeling. Trends Genet. 1990;6:121
  33. Sato T, Ito A, Mori Y, et al. Hormonal regulation of collagenolysis in uterine cervical fibroblasts (Modulation of synthesis of procollagenase, prostromelysin and TIMPs by progesterone and estradiol-17 beta). Biochem J. 1991;275:645
  34. Guerne P-A, Terkeltaub RA, Zuraw BL, et al. Inflammatory microcrystals stimulate interleukin-6 production and secretion from human monocytes and synoviocytes. Arthritis Rheum. 1989;32:1443
  35. Martel-Pelletier J, Zafarullah M, Kodama S, et al. In vitro effects of interleukin 1 on the synthesis of metalloproteinases, TIMP, plasminogen activators and inhibitors in human articular cartilage. J Rheumatol. 1991;18(Suppl 27):80
  36. Wilbrink B, Niefeld J, Otter W, et al. Role of TNF-α in relation to IL-1 and IL-6 in the proteoglycan turnover of human articulrar cartilage. Br J Rheumatol. 1991;30:265
  37. Guerne P-A, Carson DA, Lotz MG. IL-6 production by human articular chondrocytes (Modulation of its synthesis by cytokines, growth factors and hormones in vitro). J Immunol. 1990;144:499
  38. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;772:1627
  39. DeMarco D, Kunkel SL, Strieter RM, et al. Interleukin-1 induced gene expression of neutrophil activating protein (interleukin-8) and monocyte chemotactic peptide in human synovial cells. Biochem Biophy Res Commun. 1991;174:411
  40. Elford PR, Cooper PH. Changes with age in the glycosaminoglycans of human articular cartilage. Ann Rheum Dis. 1991;38:371
  41. Nishimura M, Segami N, Kaneyama K, et al. Proinflammatory cytokines and arthroscopic findings of patient with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg. 2002;40:68
  42. Attur MG, Dave M, Akamatsu M, et al. Osteoarthritis or osteoarthrosis: The definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage. 2002;10:1
  43. Sukedai M, Tominaga K, Habu M, et al. Involvement of tumor necrosis factor-α and interleukin-8 in antigen-induced arthritis of the rabbit temporomandibular joint. J Oral Pathol Med. 2004;33:102
  44. Kamada M, Irahara M, Maegawa M, et al. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol Obstet Invest. 2001;52:82
  45. Roon JA, Roy JL, Gmelig MFH, et al. Prevention and reversal cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum. 1996;39:829
  46. Joosten LA, Lubberts E, Durez P. Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis (Protective effect of interleukin-4 and interleukin-10 on cartilage destruction). Arthritis Rheum. 1997;40:249
  47. Lubberts E, Joosten LA, Helson MMA, et al. Regulatory role of interleukin-10 in joint inflammation and cartilage destruction in murine streptococcal cell wall (SCW) arthritis (More therapeutic benefit with IL-4/IL-10 combination therapy than with IL-10 treatment alone). Cytokine. 1998;10:361
  48. Cush JJ, Splawski JB, Thomas R, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:96
  49. Moos V, Fickert S, Muller B, et al. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol. 1999;26:870
  50. Iannone F, De Bari C, Dell'Accio F, et al. Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin Exp Rheumatol. 2001;19:139

PII: S0278-2391(08)00126-2

doi: 10.1016/j.joms.2008.01.034

Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 5 , Pages 882-887 , May 2008